Cite as: 562 U. S. ____ (2011)

5

Opinion of the Court

ure to warn if they have complied with all regulatory
requirements (including but not limited to warning re
quirements) and have given the warning either to the
claimant or the claimant’s physician.25 They are immu
nized from liability for punitive damages absent failure to
comply with regulatory requirements, “fraud,” “intentional
and wrongful withholding of information,” or other “crimi
nal or illegal activity.”26 And most relevant to the present
case, the Act expressly eliminates liability for a vaccine’s
unavoidable, adverse side effects:
“No vaccine manufacturer shall be liable in a civil ac
tion for damages arising from a vaccine-related injury
or death associated with the administration of a vac
cine after October 1, 1988, if the injury or death re
sulted from side effects that were unavoidable even
though the vaccine was properly prepared and was ac
companied by proper directions and warnings.”27
B
The vaccine at issue here is a DTP vaccine manufac
tured by Lederle Laboratories. It first received federal
approval in 1948 and received supplemental approvals in
1953 and 1970. Respondent Wyeth purchased Lederle in
1994 and stopped manufacturing the vaccine in 1998.
Hannah Bruesewitz was born on October 20, 1991. Her
pediatrician administered doses of the DTP vaccine ac
cording to the Center for Disease Control’s recommended
childhood immunization schedule. Within 24 hours of her
April 1992 vaccination, Hannah started to experience
——————
25 See §300aa–22(b)(2), (c). The immunity does not apply if the plain
tiff establishes by clear and convincing evidence that the manufacturer
was negligent, or was guilty of fraud, intentional and wrongful with
holding of information, or other unlawful activity. See §§300aa–
22(b)(2), 300aa–23(d)(2).
26 §300aa–23(d)(2).
27 §300aa–22(b)(1).

